November 10, 202527.1 MBSA Technologies

India’s Pharmaceutical Evolution – The Institutional Rise of Global Capability Centres

India's pharma sector is becoming a global innovation powerhouse, led by GCCs driving AI-powered R&D and advanced analytics, supported by key policies to lead life sciences innovation by 2035.

Categories:
Pharma AI
GCC
FY 2025
5 views2 downloads

This white paper explores how India is transforming from a manufacturing hub into a global innovation powerhouse for the pharmaceutical industry. It highlights the rise of Global Capability Centres (GCCs) driving AI-powered R&D, digital regulatory systems, and advanced analytics. The paper examines key policy catalysts, state-level infrastructure, and the strategic evolution positioning India at the forefront of life sciences innovation by 2035.

Share this white paper:

Ready to Download?

Get instant access to this comprehensive white paper and discover actionable insights.

Explore More Resources